Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results
Cancer
 
Search Results



Your search returned 1870 record(s).

Page 160 of 187  |  Previous Page   |  Next Page

Cancer Type:   Sort By:

This Search was Made Possible by:


  Survival: Patients: Toxicity: Treatment: Hospital: Country: Date:
1591 6.4 months Advanced NSCLC 2 Immunotherapy
Hospital Hermanos Ameijeiras Cuba 3/2008
Treatment Details: Patients: This phase II study involved 80 patients with advanced non-small-cell lung cancer. The median age was 55.5, ranging from 30 to 78 years of age. The majority (74%) were men. All
 
1592 6.4 months Metastatic colorectal cancer 4 Biologic therapy
Memorial Sloan-Kettering Cancer Center United States 4/2004
Treatment Details: Patients: This Phase II trial involved 57 patients with metastatic colorectal cancer. Patients were required to have received a chemotherapy drug (irinotecan), either alone or in a combinat
 
1593 6.4 months Metastatic colorectal cancer 4 Biologic therapy
Memorial Sloan-Kettering Cancer Center United States 4/2004
Treatment Details: Patients: This Phase II trial involved 57 patients with metastatic colorectal cancer. Patients were required to have received a chemotherapy drug (irinotecan), either alone or in a combinat
 
1594 6.4 months Newly diagnosed GBM 4 Chemotherapy
Surgery
CHU Timone France 5/2004
Treatment Details: Patients: This Phase II study involved 32 newly diagnosed patients with glioblastoma multiforme. All patients were over 70 years of age. Treatment: Treatments consisted of the administra
 
1595 6.3 months Recurrent GBM 4 Chemotherapy
Johns Hopkins Oncology Center United States 7/2001
Treatment Details: Patients: A total of 12 patients were enrolled onto this trial. Ten patients had glioblastoma multiforme. Treatment: Treatment consisted of the drug, suramin. Suramin was originally us
 
1596 6.3 months Recurrect colorectal adenocarcinoma 4 Biologic therapy
Vanderbilt University Medical Center United States 12/2005
Treatment Details: Patients: This Phase II study involved 110 patients with metastatic colorectal cancer. The patients were randomized into two groups. Group A had 55 patients (36 men, 19 women; 48 Caucasian
 
1597 6.3 months Metastatic colorectal cancer 4 Biologic therapy
University Hospital Gasthuisberg Belgium 1/2008
Treatment Details: Patients: This phase III study involved 176 patients with metastatic colorectal cancer. The median age was sixty-two, ranging from 32 to 83 years old. These patients had received from 2 t
 
1598 6.3 months Advanced NSCLC 4 Chemotherapy
Martha-Maria City Hospital Germany 11/2005
Treatment Details: Patients: This Phase III study involved a total of 208 patients. Patients were divided into two groups: Group A had 103 patients and Group B had 105 patients. The median age for patients i
 
1599 6.3 months GBM 5 Biologic therapy
National Cancer Institute United States 12/2012
Treatment Details: Patients: Patients in this phase 2 study were divided into 2 groups based on their particular form of brain cancer. Group A consisted of 32 glioblastoma multiforme patients with a median a
 
1600 6.3 months Advanced urothelial cancer 4 Chemotherapy
Seoul National University College of Medicine Korea 11/2014
Treatment Details: Patients: This study involved 42 advanced urothelial cancer patients who had been previously treated with gemcitabine and platinum. The median patient age was 65 years and 76.2% were male.
 
Page 160 of 187  | Previous Page  | Next Page